Laurence Shumway

Larry Shumway joined Flagship Pioneering in 2018 and serves as Vice President, Intellectual Property Counsel. He is responsible for developing, implementing, and managing IP and related legal strategies for Flagship’s enterprise companies, as well as setting institutional policies and designing educational courses.

He has more than 15 years of industry and law firm experience, specializing in biologics and biotechnology. As inhouse counsel at Takeda, GSK, and Novartis, he designed and managed complex IP portfolios around innovative large molecule platforms and assets in oncology, immunology, and vaccines, and led IP and legal functions on transactional and project teams. He began his legal career in the IP boutique firms of Hamilton, Brook, Smith and Reynolds, PC and Finnegan, LLP, focusing on evaluating and protecting complex biologics and inventions at the interface of biology with different technical fields.

Larry studied law at Boston College (J.D.) and earned his Ph.D. in biophysics from Harvard University on an NSF fellowship. He earned B.S. degrees in biochemistry and molecular biology and in mathematics and statistics from the University of Massachusetts, Amherst, on Goldwater, Beckman, and Pfizer scholarships.